New emerging targets in cancer immunotherapy: the role of Cluster of Differentiation 40 (CD40/TNFR5)

Piechutta, M; Berghoff, AS

Berghoff, AS (reprint author), Med Univ Vienna, Clin Div Oncol, Dept Med 1, Vienna, Austria.

ESMO OPEN, 2019; 4 ():

Abstract

Cluster of differentiation 40 (CD40) is a member of the tumour necrosis factor family and a new immunemodulating target in cancer treatment. B cells, ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索